Business
Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package th...
About this update from Else Nutrition Holdings Inc
[{"type":"text","content":"\n\n\nElse Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\nCanada NewsWire\n\n\nNew Federal Budget Agreement Ends Government Shutdown and Expedites FDA Pathway for Innovative, Non-Soy, Plant-Based Infant Nutrition Under Operation Stork Speed\nVANCOUVER, BC, Nov. 18, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (\"Else\" or the \"Company\"), a global pioneer in whole-food, plant-based nutrition for babies, toddlers, children and adults, today recognizes the bicameral, bipartisan passage of the U.S. Government budget for Fiscal Year 2026 that officially ended the U.S. Government shutdown, marking a major milestone for the Company. The budget signed into law by President Donald Trump includes Report Language bolstering Operation Stork Speed and also directs the Food & Drug Administration (FDA) to streamline regulatory pathways for new infant formulas, specifically including plant-based, non-soy, non-dairy formula solutions, a report provision secured directly through the Company's Government Affairs initiatives.\n\n\n\n\n\n\n\nThis legislative milestone is incorporated into the Congressional Directives of the passed budget through H. Rept. 119-172 and is expected to streamline and accelerate regulatory pathways and guidance at the FDA for plant-based, non-soy, non-dairy formula. Else expects that, as FDA employees return to work now that the U.S. Government shutdown has ended, this guidance process may begin in earnest, marking a pivotal moment for American families seeking inclusive and safe nutritional alternatives.\n\"For too many parents, the absence of truly inclusive formula options has been a daily worry,\" said Hamutal Yitzhak, Co-Founder & CEO of Else Nutrition. \"Congress has sent a clear directive: U.S. regulatory policy will soon catch up to the reality that babies' nutritional needs and famil...